El Paso, TEXAS3 Active Studies

Interstitial Cystitis Clinical Trials in El Paso, TEXAS

Find 3 actively recruiting interstitial cystitis clinical trials in El Paso, TEXAS. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
991
Enrolling

Recruiting Interstitial Cystitis Studies in El Paso

About Interstitial Cystitis Clinical Trials in El Paso

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 3 interstitial cystitis clinical trials recruiting participants in El Paso, TEXAS. These studies are seeking a combined 991 participants. Research is being sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, Akebia Therapeutics, Intuitive Surgical. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in El Paso — FAQ

Are there interstitial cystitis clinical trials in El Paso?

Yes, there are 3 interstitial cystitis clinical trials currently recruiting in El Paso, TEXAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in El Paso?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the El Paso research site will contact you about next steps.

Are clinical trials in El Paso free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many El Paso studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 3 active trials in El Paso are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated March 2, 2026 from ClinicalTrials.gov